Lichen Depsides and Tridepsides: Progress in Pharmacological Approaches
Isabel Ureña-Vacas1, Elena González-Burgos1, Pradeep Kumar Divakar1
1Department of Pharmacology, Pharmacognosy and Botany, Faculty of Pharmacy, Complutense University of Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain.
Lichen compounds called depsides and tridepsides show promising pharmacological effects, including antioxidant and antimicrobial activities. Further in vivo and clinical research is needed to explore their full potential.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Medicinal Botany
Background:
- Depsides and tridepsides are secondary metabolites predominantly found in lichens.
- Recent years have seen a surge in scientific interest regarding their diverse pharmacological properties.
Purpose of the Study:
- To review and synthesize current research on the biological effects and mechanisms of action of lichen-derived depsides and tridepsides.
- To identify knowledge gaps and suggest future research directions in the field.
Main Methods:
- Comprehensive literature review of studies investigating the pharmacology of lichen depsides and tridepsides.
- Analysis of reported biological activities, mechanisms of action, and study methodologies (in vitro, in silico, in vivo).
Main Results:
- Atranorin, gyrophoric acid, diffractaic acid, and lecanoric acid are the most extensively studied compounds.
- Antioxidant, cytotoxic, and antimicrobial activities are the most frequently reported, primarily from in vitro investigations.
- Limited in silico and in vivo studies exist, with no clinical trials conducted to date.
Conclusions:
- Lichen depsides and tridepsides exhibit significant pharmacological potential, particularly in antioxidant, cytotoxic, and antimicrobial applications.
- There is a critical need for more robust in vivo studies and human clinical trials to validate these findings.
- A vast number of depsides and tridepsides remain underexplored, representing opportunities for future drug discovery.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
12:34Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
Published on: January 12, 2024
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
